Cargando…

Should postoperative thromboprophylaxis be used after anterior cruciate ligament reconstruction?

OBJECTIVES: Anterior cruciate ligament (ACL) reconstruction is the ligament surgery that is performed most often in France. The French Society of Anesthesia-Resuscitation (SFAR) recommends systematic thromboprophylaxis in the postoperative period. The objective of this study was to evaluate the inci...

Descripción completa

Detalles Bibliográficos
Autores principales: Iniguez, Xavier Bayle, Cassard, Xavier, Vinciguerra, Bruno, Murgier, Jérôme
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7917855/
http://dx.doi.org/10.1177/2325967121S00019
_version_ 1783657793594589184
author Iniguez, Xavier Bayle
Cassard, Xavier
Vinciguerra, Bruno
Murgier, Jérôme
author_facet Iniguez, Xavier Bayle
Cassard, Xavier
Vinciguerra, Bruno
Murgier, Jérôme
author_sort Iniguez, Xavier Bayle
collection PubMed
description OBJECTIVES: Anterior cruciate ligament (ACL) reconstruction is the ligament surgery that is performed most often in France. The French Society of Anesthesia-Resuscitation (SFAR) recommends systematic thromboprophylaxis in the postoperative period. The objective of this study was to evaluate the incidence of symptomatic phlebitis after ACL reconstruction. The hypothesis was that it is the same with or without thromboprophylaxis. METHODS: This was a retrospective multicentric, multi-operator, case control study. Of the four operators concerned, two did not prescribe postoperative thromboprophylaxis except in special cases (major risk factors) and two prescribed low molecular weight heparin for ten days. All patients who underwent primary ACL reconstruction surgery between 1 July 2018 and 15 February 2020 were followed up by telephone within a minimum of 3 months. All follow-up letters were also consulted to cross-check information. All patients with a history of thromboembolic events (TE) or those who had undergone multiple ligament surgery were excluded. RESULTS: 249 patients were re-contacted in the anticoagulant free group and 221 in the anticoagulant group. The 2 groups were similar. The mean age was 29 years. 60% were male. There were 2 cases of phlebitis in each group. The initial hypothesis was therefore confirmed with an equivalent incidence of symptomatic phlebitis with or without postoperative anticoagulation. In fact, the incidence of symptomatic TE reported with or without thromboprophylaxis in the different Swedish, American and English registries varied from 0.2 to 0.5%, whereas in studies to identify asymptomatic TE, the incidence was 9 to 14%. Our study has some limitations, notably due to the retrospective nature and the absence of ultrasound analysis. However, loss of information is low given that the study is recent and considering the study population. Furthermore, we identified no risk factors. CONCLUSION: The incidence of symptomatic phlebitis after ACL reconstruction is equivalent with or without thromboprophylaxis. This raises the question of the need for postoperative thromboprophylaxis, particularly in patients without risk factors. National recommendations could be made based on these findings and those in the international literature.
format Online
Article
Text
id pubmed-7917855
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher SAGE Publications
record_format MEDLINE/PubMed
spelling pubmed-79178552021-03-11 Should postoperative thromboprophylaxis be used after anterior cruciate ligament reconstruction? Iniguez, Xavier Bayle Cassard, Xavier Vinciguerra, Bruno Murgier, Jérôme Orthop J Sports Med Article OBJECTIVES: Anterior cruciate ligament (ACL) reconstruction is the ligament surgery that is performed most often in France. The French Society of Anesthesia-Resuscitation (SFAR) recommends systematic thromboprophylaxis in the postoperative period. The objective of this study was to evaluate the incidence of symptomatic phlebitis after ACL reconstruction. The hypothesis was that it is the same with or without thromboprophylaxis. METHODS: This was a retrospective multicentric, multi-operator, case control study. Of the four operators concerned, two did not prescribe postoperative thromboprophylaxis except in special cases (major risk factors) and two prescribed low molecular weight heparin for ten days. All patients who underwent primary ACL reconstruction surgery between 1 July 2018 and 15 February 2020 were followed up by telephone within a minimum of 3 months. All follow-up letters were also consulted to cross-check information. All patients with a history of thromboembolic events (TE) or those who had undergone multiple ligament surgery were excluded. RESULTS: 249 patients were re-contacted in the anticoagulant free group and 221 in the anticoagulant group. The 2 groups were similar. The mean age was 29 years. 60% were male. There were 2 cases of phlebitis in each group. The initial hypothesis was therefore confirmed with an equivalent incidence of symptomatic phlebitis with or without postoperative anticoagulation. In fact, the incidence of symptomatic TE reported with or without thromboprophylaxis in the different Swedish, American and English registries varied from 0.2 to 0.5%, whereas in studies to identify asymptomatic TE, the incidence was 9 to 14%. Our study has some limitations, notably due to the retrospective nature and the absence of ultrasound analysis. However, loss of information is low given that the study is recent and considering the study population. Furthermore, we identified no risk factors. CONCLUSION: The incidence of symptomatic phlebitis after ACL reconstruction is equivalent with or without thromboprophylaxis. This raises the question of the need for postoperative thromboprophylaxis, particularly in patients without risk factors. National recommendations could be made based on these findings and those in the international literature. SAGE Publications 2021-02-26 /pmc/articles/PMC7917855/ http://dx.doi.org/10.1177/2325967121S00019 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by-nc-nd/4.0/ This open-access article is published and distributed under the Creative Commons Attribution - NonCommercial - No Derivatives License (https://creativecommons.org/licenses/by-nc-nd/4.0/), which permits the noncommercial use, distribution, and reproduction of the article in any medium, provided the original author and source are credited. You may not alter, transform, or build upon this article without the permission of the Author(s). For article reuse guidelines, please visit SAGE’s website at http://www.sagepub.com/journals-permissions.
spellingShingle Article
Iniguez, Xavier Bayle
Cassard, Xavier
Vinciguerra, Bruno
Murgier, Jérôme
Should postoperative thromboprophylaxis be used after anterior cruciate ligament reconstruction?
title Should postoperative thromboprophylaxis be used after anterior cruciate ligament reconstruction?
title_full Should postoperative thromboprophylaxis be used after anterior cruciate ligament reconstruction?
title_fullStr Should postoperative thromboprophylaxis be used after anterior cruciate ligament reconstruction?
title_full_unstemmed Should postoperative thromboprophylaxis be used after anterior cruciate ligament reconstruction?
title_short Should postoperative thromboprophylaxis be used after anterior cruciate ligament reconstruction?
title_sort should postoperative thromboprophylaxis be used after anterior cruciate ligament reconstruction?
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7917855/
http://dx.doi.org/10.1177/2325967121S00019
work_keys_str_mv AT iniguezxavierbayle shouldpostoperativethromboprophylaxisbeusedafteranteriorcruciateligamentreconstruction
AT cassardxavier shouldpostoperativethromboprophylaxisbeusedafteranteriorcruciateligamentreconstruction
AT vinciguerrabruno shouldpostoperativethromboprophylaxisbeusedafteranteriorcruciateligamentreconstruction
AT murgierjerome shouldpostoperativethromboprophylaxisbeusedafteranteriorcruciateligamentreconstruction